Skip to content

Total debt at other companies

Axogen logo
AxogenAXGN
$20.64M-69.8%
Globus Medical logo
Globus MedicalGMED
$116.26M+25.0%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Stryker logo
StrykerSYK
AbbVie logo
AbbVieABBV
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

Plus components not separately reported this period.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's total debt?
Integra LifeSciences (IART) reported total debt of $1.98B in Q1 2026.
How has Integra LifeSciences's total debt changed year-over-year?
Integra LifeSciences's total debt increased by 3.2% year-over-year, from $1.92B to $1.98B.
What is the long-term trend for Integra LifeSciences's total debt?
Over 5 years (2020 to 2025), Integra LifeSciences's total debt has grown at a 13.0% compound annual growth rate (CAGR), from $1.03B to $1.91B.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.